Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - michael+milone
1
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Treating Prostate Cancer with Novel Sugar-Antigen-Targeting CAR-T Cells
Problem: While the 5-year relative survival rate for patients with local or regional prostate cancer is nearly 100%, the 5-year relative survival rate drops to 32% for patients with metastatic or advanced disease. These patients may initially respond to available therapies, but most patients will develop therapy resistance and succumb to disease. Solution: A...
Published: 6/20/2024
|
Inventor(s):
Mark Greene
,
Michael Milone
Keywords(s):
Cell Therapy
,
Oncology
Category(s):
Technology Classifications > Therapeutics